Non-coding RNAs including miRNAs, piRNAs, and tRNAs in human cancer

Oncotarget

Volumn 6, Issue 27, 2015, Pages 23055-23057

  Heyns, Mieke ^a   Kovalchuk, Olga ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Cancer; miRNA; Non coding RNA; piRNA; tRNA

Indexed keywords

MICRORNA; PIWI INTERACTING RNA; PIWI PROTEIN; TRANSFER RNA; UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMATIN CONDENSATION; COMPLEX FORMATION; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; ENDOMETRIUM CANCER; EPIGENETICS; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; MALIGNANT TRANSFORMATION; OVARY CANCER; PROSTATE CANCER; RNA DEGRADATION; RNA TRANSCRIPTION; STRESS; TESTIS CANCER; THERAPY RESISTANCE; TRANSCRIPTION ELONGATION; UPREGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; NEOPLASMS;

CELL PROLIFERATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; NEOPLASMS; RNA, TRANSFER; RNA, UNTRANSLATED;

EID: 84943389732     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5048     Document Type: Article

References (34)

1. Ponting CP and Belgard TG. Transcribed dark matter: meaning or myth? Human Molecular Genetics. 2010;19:R162-168.
2. Stein LD. Human genome:end of the beginning. Nature. 2004;431:915-916.
3. Mattick JS and Makunin IV. Non-coding RNA. Human molecular genetics. 2006;15(suppl 1):R17-R29.
4. Gibb EA, Brown CJ and Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular cancer. 2011;10:38-55.
5. Iorio MV and Croce CM. MicroRNA dysregulation in cancer:diagnostics, monitoring and therapeutics. A comprehensive review. EMBO molecular medicine. 2012; 4:143-159.
6. Koturbash I, Zemp FJ, Pogribny I and Kovalchuk O. Small molecules with big effects:the role of the microRNAome in cancer and carcinogenesis. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2011;722:94-105.
7. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nature Reviews Cancer. 2006;6:259-269.
8. Cheng J, Guo J-M, Xiao B-X, Miao Y, Jiang Z, Zhou H and Li Q-N. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clinica Chimica Acta. 2011;412:1621-1625.
9. Martens-Uzunova ES, Olvedy M and Jenster G. Beyond microRNA-novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer letters. 2013; 340:201-211.
10. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F and Negrini M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:2999-3004.
11. Han L, Witmer PDW, Casey E, Valle D and Sukumar S. DNA methylation regulates MicroRNA expression. Cancer biology & therapy. 2007;6:1290-1294.
12. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Menard S, Croce CM and Tagliabue E. microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 2009; 69:2195-2200.
13. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ. RAS is regulated by the let-7 microRNA family. Cell. 2005; 120:635-647.
14. Su Z, Yang Z, Xu Y, Chen Y and Yu Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 2015; 6:8474-8490.
15. Luzhna L and Kovalchuk O. Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues. Oncoscience. 2014;1:751-762.
16. Ujihira T, Ikeda K, Suzuki T, Yamaga R, Sato W, HorieInoue K, Shigekawa T, Osaki A, Saeki T, Okamoto K, Takeda S and Inoue S. MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer. Scientific reports. 2015;5:7641.
17. Sanchez-Diaz PC, Hsiao TH, Zou Y, Sugalski AJ, HeimHall J, Chen Y, Langevin AM and Hung JY. In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma. Oncoscience. 2014;1:599-608.
18. Zabolotneva AA, Zhavoronkov AA, Shegay PV, Gaifullin NM, Alekseev BY, Roumiantsev SA, Garazha AV, Kovalchuk O, Aravin A and Buzdin AA. A systematic experimental evaluation of microRNA markers of human bladder cancer. Frontiers in genetics. 2013;4:247.
19. Sun Y, Wang M, Lin G, Sun S, Li X, Qi J and Li J. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PloS one. 2012;7:e47003.
20. Margue C, Reinsbach S, Philippidou D, Beaume N, Walters C, Schneider JG, Nashan D, Behrmann I and Kreis S. Comparison of a healthy miRNome with melanoma patient miRNomes:are microRNAs suitable serum biomarkers for cancer? Oncotarget. 2015;6:12110-12127.
21. Navarro A, Diaz T, Tovar N, Pedrosa F, Tejero R, Cibeira MT, Magnano L, Rosinol L, Monzo M, Blade J and Fernandez de Larrea C. A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma. Oncotarget. 2015;6:1874-1883.
22. Ferreira HJ, Heyn H, Garcia del Muro X, Vidal A, Larriba S, Muñoz C, Villanueva A and Esteller M. Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis. epigenetics. 2014;9:113-118.
23. Lu Y, Li C, Zhang K, Sun H, Tao D, Liu Y, Zhang S and Ma Y. Identification of piRNAs in Hela cells by massive parallel sequencing. BMB reports. 2010;43:635-641.
24. Liu X, Sun Y, Guo J, Ma H, Li J, Dong B, Jin G, Zhang J, Wu J, Meng L and Shou C. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. International journal of cancer Journal international du cancer. 2006;118:1922-1929.
25. Lee JH, Schütte D, Wulf G, Füzesi L, Radzun H-J, Schweyer S, Engel W and Nayernia K. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Human molecular genetics. 2006;15:201-211.
26. Qiao D, Zeeman A-M, Deng W, Looijenga L and Lin H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene. 2002;21:3988-3999.
27. Hashim A, Rizzo F, Marchese G, Ravo M, Tarallo R, Nassa G, Giurato G, Santamaria G, Cordella A, Cantarella C and Weisz A. RNA sequencing identifies specific PIWIinteracting small non-coding RNA expression patterns in breast cancer. Oncotarget. 2014;5:9901-9910.
28. Wang QE, Han C, Milum K and Wani AA. Stem cell protein Piwil2 modulates chromatin modifications upon cisplatin treatment. Mutation research. 2011;708:59-68.
29. Zhang H, Ren Y, Xu H, Pang D, Duan C and Liu C. The expression of stem cell protein Piwil2 and piR-932 in breast cancer. Surgical oncology. 2013;22:217-223.
30. Winter AG, Sourvinos G, Allison SJ, Tosh K, Scott PH, Spandidos DA and White RJ. RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. Proceedings of the National Academy of Sciences. 2000;97:12619-12624.
31. Marshall L, Kenneth NS and White RJ. Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell. 2008;133:78-89.
32. Zouridis H and Hatzimanikatis V. Effects of codon distributions and tRNA competition on protein translation. Biophysical journal. 2008;95:1018-1033.
33. Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR and Pan T. tRNA over-expression in breast cancer and functional consequences. Nucleic acids research. 2009; 37:7268-7280.
34. Dhahbi JM, Spindler SR, Atamna H, Boffelli D and Martin DI. Deep Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and YRNA Fragment Expression Associated with Breast Cancer. Biomarkers in cancer. 2014; 6:37-47.